NAPSA Antikörper (AA 20-158)
Kurzübersicht für NAPSA Antikörper (AA 20-158) (ABIN1724854)
Target
Alle NAPSA Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
Klon
-
-
Bindungsspezifität
- AA 20-158
-
Verwendungszweck
- NAPSA Antibody
-
Aufreinigung
- Purified antibody
-
Immunogen
- Purified recombinant fragment of human NAPSA (AA: 20-158) expressed in E. Coli.
-
Isotyp
- IgG1
-
-
-
-
Applikationshinweise
- ELISA: 1/10000
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
- Purified antibody in PBS with 0.05 % sodium azide.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- 4 °C,-20 °C
-
Informationen zur Lagerung
- Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze/thaw cycles.
-
-
-
: "Comparison of the expression levels of napsin A, thyroid transcription factor-1, and p63 in nonsmall cell lung cancer using cytocentrifuged bronchial brushings." in: Cancer cytopathology, Vol. 119, Issue 5, pp. 335-45, (2011) (PubMed).
-
-
- NAPSA (Napsin A Aspartic Peptidase (NAPSA))
-
Andere Bezeichnung
- NAPSA
-
Hintergrund
-
The activation peptides of aspartic proteinases plays role as inhibitors of the active site. These peptide segments, or pro-parts, are deemed important for correct folding, targeting, and control of the activation of aspartic proteinase zymogens. The pronapsin A gene is expressed predominantly in lung and kidney. Its translation product is predicted to be a fully functional, glycosylated aspartic proteinase precursor containing an RGD motif and an additional 18 residues at its C-terminus.
-
Molekulargewicht
- 45.4 kDa
-
Gen-ID
- 9476
-
UniProt
- O96009
-
Pathways
- Tube Formation, Asymmetric Protein Localization, Embryonic Body Morphogenesis
Target
-